Rameis H, Hitzenberger G, Horwatitsch H
Dtsch Med Wochenschr. 1979 Jun 15;104(24):881-3. doi: 10.1055/s-0028-1104007.
The biological availability of spironolactone in two different galenic preparations (Spiro-Tablinen and Aldactone-100 Caps) was investigated in a single-blind, randomised, cross-over study in six healthy probands. The serum concentration of canrenone after oral intake of spironolactone (100 mg) was investigated in the steady state as well as the renal excretion of canrenone. There were no statistically significant differences between the two preparations either in the course of the serum concentration of canrenone or in the cumulative renal excretion.
在一项针对6名健康受试者的单盲、随机、交叉研究中,对两种不同剂型(螺内酯片和安体舒通100胶囊)的螺内酯生物利用度进行了研究。在稳态下研究了口服螺内酯(100毫克)后坎利酮的血清浓度以及坎利酮的肾脏排泄情况。两种制剂在坎利酮血清浓度过程或累积肾脏排泄方面均无统计学显著差异。